Fate Therapeutics
FATE
FATE
130 hedge funds and large institutions have $76.2M invested in Fate Therapeutics in 2025 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 40 increasing their positions, 40 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
54% less capital invested
Capital invested by funds: $166M → $76.2M (-$90M)
57% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 42
Holders
130
Holding in Top 10
–
Calls
$64K
Puts
$6K
Top Buyers
| 1 | +$6.16M | |
| 2 | +$1.37M | |
| 3 | +$913K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$789K |
| 5 |
MAM
Monaco Asset Management
Monaco
|
+$649K |
Top Sellers
| 1 | -$7.99M | |
| 2 | -$5.87M | |
| 3 | -$5.03M | |
| 4 |
SCM
Superstring Capital Management
New York
|
-$2.28M |
| 5 |
D.E. Shaw & Co
New York
|
-$872K |
